Topical photodynamic therapy at low fluence rates - theory and practice

被引:61
作者
Langmack, K
Mehta, R
Twyman, P
Norris, P
机构
[1] Addenbrookes Hosp, Dept Phys Med, Cambridge CB2 2QQ, England
[2] Addenbrookes Hosp, Dept Dermatol, Cambridge CB2 2QQ, England
关键词
photodynamic therapy; mathematical model; fluence rate; clinical trial;
D O I
10.1016/S1011-1344(01)00116-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Photodynamic Therapy (PDT), with topically applied 5-aminolaevulinic acid as the photosensitiser, is an effective treatment for various malignant and pre-malignant skin conditions. Several studies have shown the importance of fluence rate as well as fluence in the efficacy of PDT. We propose a measure of PDT efficacy, Photodynamic Damage Dose (PDD), which uses the product of instantaneous fluence rates, photosensitiser concentrations and oxygen concentrations in its calculation. We derive a qualitative numerical model of PDT and verify it by demonstrating an inverse fluence rate effect, increased efficacy of fractionated PDT, PDT induced hypoxia, and the dependence of photobleaching on fluence rate under certain circumstances. We recommend that fluence, fluence rate and any fractionation regime used should be detailed when reporting a trial as altering any of these has significant effects on PDT efficacy. The model predicts that low fluence rate irradiations should be as effective as high fluence rate irradiations if carried out over the same length of time. To test this we build a light emitting diode-based lamp (fluence rate of 7 mW cm(-2) at 635 nm) and used it to treat 32 superficial basal cell carcinomas on 22 patients (30 min treatment time, fluence 12.6 J cm(-2)). The complete response rate at one year was 84%, which is comparable to that achieved using higher fluence rate sources for similar treatment times. We conclude that this robust, inexpensive light source is effective for topical PDT. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 30 条
[1]   OXYGEN-CONSUMPTION AND DIFFUSION EFFECTS IN PHOTODYNAMIC THERAPY [J].
FOSTER, TH ;
MURANT, RS ;
BRYANT, RG ;
KNOX, RS ;
GIBSON, SL ;
HILF, R .
RADIATION RESEARCH, 1991, 126 (03) :296-303
[2]  
FOSTER TH, 1993, CANCER RES, V53, P1249
[3]   DOSIMETRY IN PHOTODYNAMIC THERAPY - OXYGEN AND THE CRITICAL IMPORTANCE OF CAPILLARY DENSITY [J].
FOSTER, TH ;
GAO, L .
RADIATION RESEARCH, 1992, 130 (03) :379-383
[4]   Photodynamic therapy in dermatology [J].
Fritsch, C ;
Goerz, G ;
Ruzicka, T .
ARCHIVES OF DERMATOLOGY, 1998, 134 (02) :207-214
[5]   The mechanism of photofrin(R) photobleaching and its consequences for photodynamic dosimetry [J].
Georgakoudi, I ;
Nichols, MG ;
Foster, TH .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1997, 65 (01) :135-144
[6]   Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry [J].
Georgakoudi, I ;
Foster, TH .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1998, 67 (06) :612-625
[7]   PDT light dosimetry revisited [J].
Grossweiner, LI .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1997, 38 (2-3) :258-268
[8]   Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy [J].
Haller, JC ;
Cairnduff, F ;
Slack, G ;
Schofield, J ;
Whitehurst, C ;
Tunstall, R ;
Brown, SB ;
Roberts, DJH .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (06) :1270-1274
[9]   A TRANSIENT MATHEMATICAL-MODEL OF OXYGEN DEPLETION DURING PHOTODYNAMIC THERAPY [J].
HENNING, JP ;
FOURNIER, RL ;
HAMPTON, JA .
RADIATION RESEARCH, 1995, 142 (02) :221-226
[10]  
Iinuma S, 1999, CANCER RES, V59, P6164